Merck & Co. Inc. DL-Notes 2025(25/27)
- BID
99.37
- ASK
99.512
- 500,000 Nom.500,000 Nom.
- 07/27, 19:44:55 PM
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
4.48
Yield spread Bundesanleihe
1.7533
Tradable for private investors
No
Minimum amount tradeable unit
2,000.00
Maturity
15/09/2027
Interest Rate
3.85 %
Currency
US Dollar
Facts & figures
Price data
| TRADE PLATFORM | ||
| LAST PRICE / YIELD | 99.371 G / 4.48 | 0 Units |
| PRICE DETERMINATION TIME | 07/27/2026 / 07:03:29 PM | |
| DAILY VOLUME (NOMINAL) | 0 | |
| YIELD SPREAD | 1.7533 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 99.4 | 99.35 |
| PREV. DAY'S PRICE | 99.37 | (07/24) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | (-) | (-) |
Master Data
| WKN | A4EGKN |
| ISIN | US58933YBP97 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | Merck & Co. Inc. |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 3.85 % |
| INTEREST RUN FROM | 09/09/2025 |
| NEXT INTEREST PAYMENT | 15/09/2026 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 1.433 % |
| TRADING CURRENCY / NOTATION | US Dollar/ Percent |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 750.00 Mil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 2,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 15/09/2027 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | No |
| BOND IS SUBORDINATED | No |
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create your free account here.
Company profile
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.